ArticleCell stress2020

Targeting immune-checkpoint inhibitor resistance mechanisms by MEK inhibitor and agonist anti-CD40 antibody combination therapy.

Daniel Baumann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.